Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Phibro Animal Health (PAHC) over the last 13 years, with Q4 2025 value amounting to $8.3 million.

  • Phibro Animal Health's Free Cash Flow rose 27393.59% to $8.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $47.3 million, marking a year-over-year increase of 20853.4%. This contributed to the annual value of $41.8 million for FY2025, which is 976.14% down from last year.
  • Phibro Animal Health's Free Cash Flow amounted to $8.3 million in Q4 2025, which was up 27393.59% from -$4.5 million recorded in Q3 2025.
  • Phibro Animal Health's Free Cash Flow's 5-year high stood at $35.4 million during Q1 2025, with a 5-year trough of -$33.9 million in Q3 2022.
  • Its 5-year average for Free Cash Flow is $2.7 million, with a median of $2.4 million in 2024.
  • As far as peak fluctuations go, Phibro Animal Health's Free Cash Flow tumbled by 83368.25% in 2022, and later skyrocketed by 201138.94% in 2025.
  • Quarter analysis of 5 years shows Phibro Animal Health's Free Cash Flow stood at $12.4 million in 2021, then tumbled by 199.0% to -$12.3 million in 2022, then surged by 267.36% to $20.6 million in 2023, then plummeted by 123.04% to -$4.7 million in 2024, then skyrocketed by 273.94% to $8.3 million in 2025.
  • Its last three reported values are $8.3 million in Q4 2025, -$4.5 million for Q3 2025, and $8.1 million during Q2 2025.